Convolvulus Arvensis

Convolvulus arvensis  Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Convolvulaceae.
Habitat Throughout India, up to 3,000 m in the Himalayas.
English Deer’s Foot.
Ayurvedic Bhadrabalaa, Hiranpadi.
Unani Lablaab.
Folk Hirankhuri, Haranpagaa.
Action Plant—cooling, anticonvulsant. Root—cathartic.
Taxonomic Cohort Genus Convolvulus (3 documented species); Family Convolvulaceae (35 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Convolvulus arvensis (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Convolvulaceae (primary family classification: Convolvulaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout India, up to 3,000 m in the Himalayas.

Across classical and vernacular Indian systems of medicine, Convolvulus arvensis is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Deer’s Foot; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Bhadrabalaa, Hiranpadi; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Lablaab; in regional Indian folk and vernacular ethnobotany as Hirankhuri, Haranpagaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Convolvulus arvensis are: Plant—cooling, anticonvulsant. Root—cathartic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Convolvulus arvensis establish the following evidence base: Plant extract—hypotensive in cats; raises coronary rate. Alkaloids—hypotensive, without vasodilation. EtOH extract—anticonvulsant in rats. Aqueous extract—exhibited muscarinic and micotinic activity. The dried rhizome contains 4.9% resin. The cathartic action of the resinous substance is about one third of that of jalap (Ipomoea purga Hayne) resin. All parts of the plant contain beta- Me-esculetin; aerial parts n-alkanes, n-alkanols, alpha-amyrin and sterols; roots gave cuscohygrine.

image2

Botanical Reference 1: Convolvulus arvensis — Botanical specimen

image3

Botanical Reference 2: Convolvulus arvensis — Botanical specimen

image4

Botanical Reference 3: Convolvulus arvensis — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Convolvulus comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Convolvulus pluricaulis (Action: Plant—brain tonic, tranquilizer used in nervine disorders, mental aberration…); Convolvulus scammonia (Action: Resin from rhizomes—hydragogue, Cathartic, administered in dropsy and anascara). Comparing Convolvulus arvensis alongside its congeners in genus Convolvulus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Convolvulaceae encompasses 35 documented medicinal species (1.93% of the 1,814-species flora). Other representative medicinal members of Convolvulaceae include: Argyreia speciosa (Vriddhadaaruka), Convolvulus pluricaulis (Shankhapushpi), Convolvulus scammonia (Scammony), Cressa cretica (Rudanti), Cuscuta epithymum (Aakaashvalli). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 35 medicinal species of family Convolvulaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Convolvulus arvensis follow the plant-part modalities specified under its therapeutic action (Plant—cooling, anticonvulsant. Root—cathartic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Convolvulus arvensis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top